Guided Therapeutics Inc. (OTCMKTS:GTHP) Short Interest Up 113.8% in August

Guided Therapeutics Inc. (OTCMKTS:GTHP) saw a large growth in short interest in August. As of August 14th, there was short interest totaling 3,028 shares, a growth of 113.8% from the July 30th total of 1,416 shares. Based on an average daily volume of 5,999 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.0% of the shares of the company are sold short.

Guided Therapeutics Price Performance

Shares of OTCMKTS GTHP traded down $0.00 during trading hours on Friday, reaching $0.23. The stock had a trading volume of 1,110 shares, compared to its average volume of 8,463. The business’s fifty day moving average is $0.27 and its two-hundred day moving average is $0.26. The company has a market cap of $22.40 million, a price-to-earnings ratio of -5.80 and a beta of 0.71. Guided Therapeutics has a twelve month low of $0.15 and a twelve month high of $0.54.

Guided Therapeutics (OTCMKTS:GTHP) last posted its quarterly earnings results on Thursday, August 13th. The company reported ($0.01) earnings per share for the quarter.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc is a medical device company focused on the development and commercialization of non‐invasive optical diagnostic platforms for women’s health. Its flagship product, the LuViva® Advanced Cervical Scan, combines hyperspectral and reflectance imaging to support the early detection of cervical epithelial abnormalities. By capturing tissue fluorescence and reflectance signatures in real time, LuViva is designed to augment traditional visual inspection methods and assist clinicians during colposcopic evaluations.

The company secured 510(k) clearance from the U.S.